PIII P3 HEALTH PARTNERS INC revenue, earnings and financials
For the quarter ended June 30, 2026, P3 HEALTH PARTNERS INC reported revenue of $386M (up 8.6% from a year earlier), net income of $7.44M and diluted EPS of −$0.63; over the last four quarters revenue was $1.50B and net income −$98.4M; for the fiscal year ended December 2025 revenue was $1.46B, down 2.8% on the year before.
PIII annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $1.46B, gross profit n/a, operating income −$270M, net income −$148M (margin -10.1%), EPS −$45.26
- Fiscal year ended Dec 2024: revenue $1.50B, gross profit n/a, operating income −$321M, net income −$136M (margin -9.1%), EPS −$54.06
- Fiscal year ended Dec 2023: revenue $1.27B, gross profit n/a, operating income −$168M, net income −$57.8M (margin -4.6%), EPS −$0.63
- Fiscal year ended Dec 2022: revenue $1.05B, gross profit n/a, operating income −$1.56B, net income −$270M (margin -25.7%), EPS −$6.50
- Fiscal year ended Dec 2021: revenue $579M, gross profit n/a, operating income −$22.7M, net income −$24.8M (margin -4.3%), EPS n/a
PIII quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $386M (up 8.6% year over year), net income $7.44M, EPS −$0.63
- Quarter ended Mar 31, 2026: revenue $386M (up 3.5% year over year), net income $1.22M, EPS $0.32
- Quarter ended Dec 31, 2025 (from the annual report): revenue $385M (up 3.8% year over year), net income −$75.5M, EPS −$23.08
- Quarter ended Sep 30, 2025: revenue $345M (down 4.7% year over year), net income −$31.6M, EPS −$9.67
- Quarter ended Jun 30, 2025: revenue $356M (down 6.2% year over year), net income −$20.4M, EPS −$6.23
- Quarter ended Mar 31, 2025: revenue $373M (down 3.9% year over year), net income −$20.5M, EPS −$6.28
- Quarter ended Dec 31, 2024 (from the annual report): revenue $371M (up 6.9% year over year), net income −$58.6M, EPS −$23.13
- Quarter ended Sep 30, 2024: revenue $362M (up 25.6% year over year), net income −$46.5M, EPS −$15.70
- Quarter ended Jun 30, 2024: revenue $379M (up 15.2% year over year), net income −$12.0M, EPS −$7.37
- Quarter ended Mar 31, 2024: revenue $388M (up 28.6% year over year), net income −$18.7M, EPS −$7.86
- Quarter ended Dec 31, 2023 (from the annual report): revenue $347M (up 34.3% year over year), net income −$25.5M, EPS −$0.20
- Quarter ended Sep 30, 2023: revenue $288M (up 16.1% year over year), net income −$13.3M, EPS −$0.12
- Quarter ended Jun 30, 2023: revenue $329M (up 22.1% year over year), net income −$9.82M, EPS −$0.09
- Quarter ended Mar 31, 2023: revenue $302M (up 10.4% year over year), net income −$9.20M, EPS −$0.22
- Quarter ended Dec 31, 2022 (from the annual report): revenue $258M, net income −$94.0M, EPS −$2.25
- Quarter ended Sep 30, 2022: revenue $248M (up 59.0% year over year), net income −$11.2M, EPS −$0.27
- Quarter ended Jun 30, 2022: revenue $269M (up 86.4% year over year), net income −$154M, EPS −$3.73
- Quarter ended Mar 31, 2022: revenue $274M (up 80.8% year over year), net income −$10.6M, EPS −$0.25
- Quarter ended Dec 2, 2021 (from the annual report): revenue $127M, net income $61.4M, EPS n/a
- Quarter ended Sep 30, 2021: revenue $156M, net income −$32.1M, EPS n/a
PIII cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$91.2M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$110M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$76.0M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$126M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$1.59M, share buybacks n/a
PIII balance sheet
- Jun 30, 2026: cash $21.3M, total assets $654M, total liabilities $517M, shareholders' equity n/a, long-term debt $98.1M
- Mar 31, 2026: cash $25.5M, total assets $674M, total liabilities $807M, shareholders' equity n/a, long-term debt $260M
- Dec 31, 2025: cash $25.0M, total assets $657M, total liabilities $797M, shareholders' equity −$155M, long-term debt $228M
- Sep 30, 2025: cash $37.7M, total assets $684M, total liabilities $665M, shareholders' equity −$18.7M, long-term debt $214M
- Jun 30, 2025: cash $38.6M, total assets $732M, total liabilities $644M, shareholders' equity $44.5M, long-term debt $102M
- Mar 31, 2025: cash $40.1M, total assets $784M, total liabilities $663M, shareholders' equity $63.3M, long-term debt $106M
- Dec 31, 2024: cash $38.8M, total assets $783M, total liabilities $634M, shareholders' equity $75.9M, long-term debt $109M
- Sep 30, 2024: cash $63.0M, total assets $833M, total liabilities $569M, shareholders' equity $121M, long-term debt $133M
What is PIII's revenue?
P3 HEALTH PARTNERS INC reported $1.50B of revenue over its last four quarters, through June 30, 2026.
Is PIII profitable?
No. P3 HEALTH PARTNERS INC lost $98.4M over the last four quarters.
What is PIII's EPS?
Diluted earnings per share over the last four quarters were −$33.06; −$0.63 in the latest quarter.